WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crispr Therapeutics Ag insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Samarth KulkarniChief Executive Officer2026-03-1610,349$48.26
$499.44kSell
James R. KasingerGeneral Counsel and Secretary2026-03-163,450$48.26
$166.50kSell
Raju PrasadChief Financial Officer2026-03-165,848$48.26
$282.22kSell
Raju PrasadChief Financial Officer2026-03-164,021$48.26
$194.05kSell
Naimish PatelChief Medical Officer2026-03-163,150$48.26
$152.02kSell
James R. KasingerGeneral Counsel and Secretary2026-03-112,800$52.80
$147.84kSell
Samarth KulkarniChief Executive Officer2026-03-119,798$52.80
$517.33kSell
James R. KasingerGeneral Counsel and Secretary2026-02-192,112$52.58
$111.05kSell
Samarth KulkarniChief Executive Officer2026-02-196,967$52.58
$366.32kSell
Raju PrasadChief Financial Officer2026-01-2234,972$45.15
$1.58MBuy

1 of 4

CRSP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRSP insiders and whales buy or sell their stock.

CRSP Shareholders

What type of owners hold Crispr Therapeutics Ag stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC10.96%10,522,057$527.05MInstitution
Celgene Corp8.92%8,557,514$428.65MInsider
Blackrock Inc7.82%7,508,178$376.08MInstitution
Orbis Allan Gray Ltd6.20%5,950,145$298.04MInstitution
Capital International Investors6.14%5,892,745$295.17MInstitution
Vertex Pharmaceuticals Europe Ltd5.61%5,380,940$269.53MInsider
Simeon George5.48%5,259,390$263.44MInsider
Bayer Global Investments Bv5.32%5,105,330$255.73MInsider
State Street Corp3.91%3,753,440$188.01MInstitution
T Rowe Price Investment Management Inc3.36%3,226,595$161.62MInstitution

1 of 3

CRSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRSP68.97%31.03%Net BuyingNet Selling
XENE97.13%2.87%Net SellingNet Selling
SRRK60.19%39.81%Net BuyingNet Selling
APGE94.85%5.15%Net SellingNet Selling
FOLD66.65%33.35%Net SellingNet Selling
View Top Biotech Stocks

Crispr Therapeutics Ag Stock Ownership FAQ

Who owns Crispr Therapeutics Ag?

Crispr Therapeutics Ag (NASDAQ: CRSP) is owned by 79.69% institutional shareholders, 35.86% Crispr Therapeutics Ag insiders, and 0.00% retail investors. Celgene Corp is the largest individual Crispr Therapeutics Ag shareholder, owning 8.56M shares representing 8.92% of the company. Celgene Corp's Crispr Therapeutics Ag shares are currently valued at $408.11M.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.